Mabgeek
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $43M
Investors
- 11
About Mabgeek
Based in Shanghai, China and established in 2016, Mabgeek is a biotech company that focused on research and development of antibody drugs. Dr. Chenghai Zhang, the founder and CEO of the company, served as R&D Director and Deputy Dean at CITIC Guojian. In 2017, the company launched an innovative antibody molecule development project. The company has a research and development team. It also has a 500-square-meter laboratory and 4 cell rooms, including 2 high-standard cell rooms that can construct stable production cell lines. Mabgeek focuses on developing innovative antibody drugs with high biological activity and druggability for key indications such as respiratory diseases, dermatitis, and nephropathy. The company's flagship product, MG-K10, is a monoclonal antibody targeting IL-4Ra. The company generates revenue by providing innovative antibody drugs and services in the field of biomedicine, targeting allergic and autoimmune diseases.
Who invested in Mabgeek
11 investors across 3 rounds
See all investors in Mabgeek
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mabgeek
Who invested in Mabgeek?
Mabgeek has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mabgeek raised?
Mabgeek has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mabgeek last raise money?
Mabgeek's most recent round on record is a Series B, in Aug 2024.
What does Mabgeek do?
Based in Shanghai, China and established in 2016, Mabgeek is a biotech company that focused on research and development of antibody drugs.
Where is Mabgeek headquartered?
Mabgeek is headquartered in Changsha, China.
Which VCs invest in companies like Mabgeek?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Mabgeek's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mabgeek? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.